WHITNEY ROSEN: Open Payments
NPI 1093364911 · MIAMISBURG, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$808 in 52 payments from 15 companies in 2025. Trend: 2023 $479 · 2024 $776 · 2025 $808
Food & beverage: $808
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $242 |
| Vanda Pharmaceuticals Inc. | 4 | $112 |
| Noven Therapeutics, LLC | 5 | $76 |
| Janssen Pharmaceuticals, Inc | 3 | $61 |
| Lundbeck LLC | 3 | $55 |
| Alkermes, Inc. | 2 | $46 |
| Neos Therapeutics, LP | 2 | $42 |
| Axsome Therapeutics, Inc. | 3 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $29 |
| Collegium Pharmaceutical, Inc. | 2 | $28 |
Products named: VRAYLAR, REXULTI, Xelstrym, SPRAVATO, FANAPT, HETLIOZ, ARISTADA, Adzenys XR-ODT.
Industry payments across OH — which companies pay providers there.
